Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Molecular Cancer Therapeutics|April 8, 2010
Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cellsRekha Rao, Srilatha Nalluri, Ravindra Kolhe, et al.
Bioorganic Chemistry|April 10, 2021
Design, synthesis and biological evaluation of anilide (dicarboxylic acid) shikonin esters as antitumor agents through targeting PI3K/Akt/mTOR signaling pathwayYingying Ma, Xiaorong Yang, Hongwei Han, et al.
Environmental Research|September 19, 2024
Impact of dual Bt-transgenic maize (2A7) on soil microbial communities and enzyme activities: A comparative study with control variety Z58Aliya Fazal, Minkai Yang, Hongwei Han, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2021
Shikonin N-benzyl matrinic acid ester derivatives as novel telomerase inhibitors with potent activity against lung cancer cell linesHongwei Han, Cong He, Xingyu Chen, et al.
European Journal of Medicinal Chemistry|February 2, 2023
PKM2/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolismHongyan Lin, Hongwei Han, Minkai Yang, et al.
Scientific Reports|May 25, 2021
Differential microbial assemblages associated with shikonin-producing Borage species in two distinct soil typesAliya Fazal, Minkai Yang, Zhongling Wen, et al.
BMC Plant Biology|May 28, 2016
Transgenic studies reveal the positive role of LeEIL-1 in regulating shikonin biosynthesis in Lithospermum erythrorhizon hairy rootsRongjun Fang, Ailan Zou, Hua Zhao, et al.
Cancer Biology & Therapy|March 13, 2009
Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cellsWarren Fiskus, Kate Buckley, Rekha Rao, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 20, 2024
A modified natural small molecule inhibits triple-negative breast cancer growth by interacting with Tubb3Hongwei Han, Minkai Yang, Zhongling Wen, et al.
Bioorganic Chemistry|November 26, 2024
Trametinib and M17, a novel small molecule inhibitor of AKT, display a synergistic antitumor effect in triple negative breast cancer cells through the AKT/mTOR and MEK/ERK pathwaysHongwei Han, Minkai Yang, Zhongling Wen, et al.
Pageof 12